Patient Square Capital LP
Q2 2025 13F Holdings
- Locationmenlo park, CA
- Num holdings
19
- Value ($000)
$277,388
- Date Filed08/11/2025
- Form type13F-HR
- CIK0001819257
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD. | SHS | G76279101 | $140.65 M | 51 % | 12,480,000 | ||
INSM INSMED INC | COM PAR $.01 | 457669307 | $36.11 M | 13 % | 358,800 | ||
ARGX ARGENX SE - ADR | SPONSORED ADR | 04016X101 | $15.99 M | 6 % | 29,000 | ||
EYPT EYEPOINT PHARMACEUTICALS, INC. | COM NEW | 30233G209 | $12.73 M | 5 % | 1,352,837 | ||
LQDA LIQUIDIA CORPORATION | COM NEW | 53635D202 | $12.71 M | 5 % | 1,020,000 | ||
OCUL OCULAR THERAPEUTIX, INC. | COM | 67576A100 | $7.59 M | 3 % | 817,699 | ||
CGEM CULLINAN THERAPEUTICS, INC. | COM | 230031106 | $6.54 M | 2 % | 868,897 | ||
KYMR KYMERA THERAPEUTICS, INC. | COM | 501575104 | $6.11 M | 2 % | 140,000 | ||
MIRM MIRUM PHARMACEUTICALS, INC. | COM | 604749101 | $5.77 M | 2 % | 113,462 | ||
SRRK SCHOLAR ROCK HOLDING CORPORATION | COM | 80706P103 | $5.45 M | 2 % | 154,000 |
Rows Per Page
10
- 10
- 50
- 100